Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.06
-0.19 (-2.62%)
Apr 1, 2026, 1:25 PM EDT - Market open
Wave Life Sciences Market Cap
Wave Life Sciences has a market cap or net worth of $1.33 billion as of April 1, 2026. Its market cap has decreased by -15.27% in one year.
Market Cap
1.33B
Enterprise Value
801.25M
1-Year Change
-15.27%
Ranking
Category
Stock Price
$7.06
Market Cap Chart
Since November 11, 2015, Wave Life Sciences's market cap has increased from $334.93M to $1.33B, an increase of 296.82%. That is a compound annual growth rate of 14.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 1.25B | -59.94% |
| Dec 31, 2025 | 3.11B | 64.89% |
| Dec 31, 2024 | 1.89B | 213.58% |
| Dec 29, 2023 | 601.65M | -1.10% |
| Dec 30, 2022 | 608.37M | 229.32% |
| Dec 31, 2021 | 184.73M | -51.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.28B |
| Monte Rosa Therapeutics | 1.26B |
| Immatics | 1.25B |
| AtaiBeckley | 1.25B |
| Biohaven | 1.25B |
| Bicara Therapeutics | 1.22B |
| MoonLake Immunotherapeutics | 1.21B |
| ORIC Pharmaceuticals | 1.19B |